Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
P/E ratio for Abbott Laboratories (ABT)
P/E ratio as of May 2024 (TTM): 35.3
According to Abbott Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 35.25. At the end of 2022 the company had a P/E ratio of 25.6.
P/E ratio history for Abbott Laboratories from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 25.6 | -27.43% |
| 2021 | 35.2 | -18.34% |
| 2020 | 43.1 | 3.71% |
| 2019 | 41.6 | -22.4% |
| 2018 | 53.6 | -74.09% |
| 2017 | 207 | 412.58% |
| 2016 | 40.4 | 167.34% |
| 2015 | 15.1 | -49.14% |
| 2014 | 29.7 | 28.56% |
| 2013 | 23.1 | 178.22% |
| 2012 | 8.30 | -6.55% |
| 2011 | 8.88 | 15.22% |
| 2010 | 7.71 | 10.37% |
| 2009 | 6.98 | -13.84% |
| 2008 | 8.10 | -29.92% |
| 2007 | 11.6 | -44.09% |
| 2006 | 20.7 | 137.23% |
| 2005 | 8.72 | -18.98% |
| 2004 | 10.8 | -9.46% |
| 2003 | 11.9 | 18.49% |
| 2002 | 10.0 | -59.52% |
| 2001 | 24.8 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.7 | -69.54% | 🇺🇸 USA |
 Novartis NVS | 27.3 | -22.43% | 🇨🇭 Switzerland |
 Pfizer PFE | 15.3 | -56.62% | 🇺🇸 USA |
 Medtronic MDT | 30.7 | -12.89% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | 38.5 | 9.24% | 🇺🇸 USA |
 Boston Scientific BSX | 88.8 | 151.89% | 🇺🇸 USA |
 Hologic HOLX | 38.8 | 9.94% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 11.4 | -67.80% | 🇺🇸 USA |
 AstraZeneca AZN | 39.0 | 10.66% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 12.9 | -63.40% | 🇬🇧 UK |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.